Literature DB >> 32350547

[Quality of care of acute ischemic stroke in Germany 2018].

B Misselwitz1, A Grau2, K Berger3, I Bruder4, C Burmeister5, P Hermanek6, R Hohnhold7, H C Koennecke8, C Matthis9, P U Heuschmann10.   

Abstract

In this overview the current quality of acute in-hospital care of stroke patients in Germany in 2018 is described based on standardized and evidence-based quality indicators. For this purpose the reports of the regional quality assurance projects for stroke care, which collaborated within the German-speaking Stroke Registers Study Group (ADSR) were analyzed. Overall, more than 280,000 acute admissions of stroke patients were documented in the included quality assurance projects. The results regarding the defined 16 quality indicators comprising diagnostics, acute treatment, rehabilitation and secondary prevention showed a high level of acute inpatient treatment of stroke in Germany. Only a few quality indicators, such as early transfer for thrombectomy indicated a great necessity for process optimization.

Entities:  

Keywords:  Acute treatment; Quality indicators; Rehabilitation; Secondary prevention; Stroke register

Year:  2020        PMID: 32350547     DOI: 10.1007/s00115-020-00908-x

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  3 in total

1.  Transient Global Amnesia (TGA): Influence of Acute Hypertension in Patients Not Adapted to Chronic Hypertension.

Authors:  Andreas Rogalewski; Anne Beyer; Anja Friedrich; Jorge Plümer; Frédéric Zuhorn; Isabell Greeve; Randolf Klingebiel; Friedrich G Woermann; Christian G Bien; Wolf-Rüdiger Schäbitz
Journal:  Front Neurol       Date:  2021-07-08       Impact factor: 4.003

2.  [Treatment reality of stroke in Germany].

Authors:  J Eyding; C Krogias; R Weber
Journal:  Nervenarzt       Date:  2020-10       Impact factor: 1.214

3.  [Telemedicine in stroke-pertinent to stroke care in Germany].

Authors:  J Barlinn; S Winzer; H Worthmann; C Urbanek; K G Häusler; A Günther; H Erdur; M Görtler; L Busetto; C Wojciechowski; J Schmitt; Y Shah; B Büchele; P Sokolowski; T Kraya; S Merkelbach; B Rosengarten; K Stangenberg-Gliss; J Weber; F Schlachetzki; M Abu-Mugheisib; M Petersen; A Schwartz; F Palm; A Jowaed; B Volbers; P Zickler; J Remi; J Bardutzky; J Bösel; H J Audebert; G J Hubert; C Gumbinger
Journal:  Nervenarzt       Date:  2021-05-27       Impact factor: 1.214

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.